Tianyao Pharmaceuticals faces penalty for market division, price-fixing in China's fluocinolone acetonide market
MLex Summary: Tianjin Tianyao Pharmaceuticals on April 1 received a notification from the Tianjin municipal Administration for Market Regulation, which said the regulator was seeking to fine the company 35.1 million...To view the full article, register now.
Already a subscriber? Click here to view full article